News Conference News AHA 2023 MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia L.A. McKeown November 11, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News AHA 2023 Coincidental Nonischemic Cardiomyopathy Impacts Prognosis in CAD Todd Neale November 09, 2023
News Conference News AHA 2022 Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START Todd Neale November 14, 2022
News Conference News AHA 2022 STRESS Shows ‘Borderline Results’ for Methylprednisolone in Infant Cardiac Surgery Yael L. Maxwell November 11, 2022
News Conference News AHA 2022 RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl Todd Neale November 10, 2022
News Conference News AHA 2022 Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION Michael O'Riordan November 09, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering Caitlin E. Cox November 08, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2022 First-line Ablation Reduces AF Progression, Boosts Quality of Life Todd Neale November 07, 2022
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE Todd Neale November 05, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Conference News AHA 2022 Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions Yael L. Maxwell November 01, 2022
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data Yael L. Maxwell November 15, 2021
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 Avoiding AF Triggers Doesn’t Improve Quality of Life: I-STOP-AFib Michael O'Riordan November 14, 2021